Abstract: The present invention relates to compounds of formula I and salts thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.
Type:
Grant
Filed:
June 28, 2010
Date of Patent:
October 23, 2012
Assignee:
Novartis AG
Inventors:
Robin Alec Fairhurst, Pascal Furet, Marc Gerspacher, Robert Mah